StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.50−0.17 (-3.64%)

Close on Nov 18, 2026Market cap $350.75MP/E –Yield –

CorMedix revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

CorMedix's revenue for the twelve months ending Jun 30, 2026 was $462.25M, up 280.5% year over year. For fiscal 2025 it was $311.71M, up 617.0% from the year before. Over ten years it grew 109.7% a year on average. The highest annual figure on record is $311.71M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$311.71M+617.0%
FY2024Dec 31, 2024$43.47M+66362.8%
FY2022Dec 31, 2022$65.41K-65.7%
FY2021Dec 31, 2021$190.94K-20.2%
FY2020Dec 31, 2020$239.23K-15.5%
FY2019Dec 31, 2019$283.27K-34.1%
FY2018Dec 31, 2018$429.80K+30.5%
FY2017Dec 31, 2017$329.33K+47.0%
FY2016Dec 31, 2016$224.11K+6.7%
FY2015Dec 31, 2015$210.13K+11.0%
FY2014Dec 31, 2014$189.27K+9359.0%
FY2013Dec 31, 2013$2.00K–
FY2012Dec 31, 2012$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$101.93M+156.5%
Q1 FY2026Mar 31, 2026$127.43M+226.1%
Q4 FY2025Dec 31, 2025$128.62M+312.1%
Q3 FY2025Sep 30, 2025$104.28M+810.2%
Q2 FY2025Jun 30, 2025$39.74M+4829.3%
Q1 FY2025Mar 31, 2025$39.08M+131480.4%
Q4 FY2024Dec 31, 2024$31.21M+457722.6%
Q3 FY2024Sep 30, 2024$11.46M+53803.5%
Q2 FY2024Jun 30, 2024$806.12K+10456.8%
Q4 FY2022Dec 31, 2022$29.70K-47.3%
Q3 FY2022Sep 30, 2022$6.82K-82.1%
Q2 FY2022Jun 30, 2022$21.25K+159.5%
Q1 FY2022Mar 31, 2022$7.64K-91.3%
Q4 FY2021Dec 31, 2021$56.40K+1.2%
Q3 FY2021Sep 30, 2021$38.09K-59.1%
Q2 FY2021Jun 30, 2021$8.19K-50.2%
Q1 FY2021Mar 31, 2021$88.26K+19.2%
Q4 FY2020Dec 31, 2020$55.71K+124.9%
Q3 FY2020Sep 30, 2020$93.02K+56.3%
Q2 FY2020Jun 30, 2020$16.44K-53.4%
Q1 FY2020Mar 31, 2020$74.05K-54.8%
Q4 FY2019Dec 31, 2019$24.78K-6.6%
Q3 FY2019Sep 30, 2019$59.53K-84.0%
Q2 FY2019Jun 30, 2019$35.27K+367.0%
Q1 FY2019Mar 31, 2019$163.69K+605.3%
Q4 FY2018Dec 31, 2018$26.52K-71.3%
Q3 FY2018Sep 30, 2018$372.51K+509.9%
Q2 FY2018Jun 30, 2018$7.55K-94.5%
Q1 FY2018Mar 31, 2018$23.21K-41.3%
Q4 FY2017Dec 31, 2017$92.53K+76367.8%
Q3 FY2017Sep 30, 2017$61.08K+37.4%
Q2 FY2017Jun 30, 2017$136.17K–
Q1 FY2017Mar 31, 2017$39.56K–
Q4 FY2016Dec 31, 2016$121–
Q3 FY2016Sep 30, 2016$44.45K–

More CorMedix figures

See a number that looks wrong?